Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

Last year, Viking Therapeutics, a mid-cap biotech, made waves after it reported excellent phase 2 results for an investigational medicine for weight loss, the industry's hottest and perhaps fastest-growing...

TERN : 3.14 (-3.38%)
Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

TERN : 3.14 (-3.38%)
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

TERN : 3.14 (-3.38%)
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

TERN : 3.14 (-3.38%)
Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

TERN : 3.14 (-3.38%)
Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

TERN : 3.14 (-3.38%)
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

TERN : 3.14 (-3.38%)
Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

TERN : 3.14 (-3.38%)
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

TERN : 3.14 (-3.38%)
Insider Purchase: Chief Executive Officer of $TERN (TERN) Buys 15,450 Shares

Amy L. Burroughs, the Chief Executive Officer of $TERN ($TERN), bought 15,450 shares of the company on 12-05-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This...

TERN : 3.14 (-3.38%)

Barchart Exclusives

Top 10 Stocks to Buy: Xpeng Enters the Top 20. Is It Too Late to Buy?
Chinese EV manufacturer Xpeng moved up six spots in Monday trading to jump into the top 20 of Barchart’s Top 100 Stocks to Buy. Up 150% over the past year, it might be too late to buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar